News

Main content
Research news

Research on Alzheimer's disease and neurodegenerative diseases is steadily progressing. In this section you will find various news items that make up the current news in this field, in Switzerland and around the world.

Long term effects of cholinesterase inhibitors on cognitive decline and mortality

The effect of cholinesterase inhibitors (CHIs) is considered to be mainly symptomatic and relatively short-lived (6 months to one year).

Similarities between Down syndrome and Alzheimer's disease

Down syndrome and Alzheimer's disease have similarities: can the same therapy work for both?

Alzheimer's disease: what is the definition?

120 years after the discovery of Alzheimer's disease, we are still searching for a definition.

Aging well with music

Learning music could be a brake on age-related cognitive decline.

Aducanumab, the drug of the future against Alzheimer's?

Aducanumab is believed to slow the progression of the disease in its early phase.

Dernière mise à jour : 11/08/2022